ChemicalBook > CAS DataBase List > Gabapentin enacarbil

Gabapentin enacarbil

Gabapentin enacarbil Structure
Gabapentin enacarbil
  • CAS No.478296-72-9
  • Chemical Name:Gabapentin enacarbil
  • CBNumber:CB01011737
  • Molecular Formula:C16H27NO6
  • Formula Weight:329.39
  • MOL File:478296-72-9.mol
Gabapentin enacarbil Property
  • Melting point 65 °C
  • Boiling point 482.0±20.0 °C(Predicted)
  • Density 1.134
  • storage temp. Store at -20°C
  • solubility DMSO:100.0(Max Conc. mg/mL);303.59(Max Conc. mM)
    Ethanol:100.0(Max Conc. mg/mL);303.59(Max Conc. mM)
    Water:0.67(Max Conc. mg/mL);2.03(Max Conc. mM)
  • form Powder
  • pka 4.72±0.10(Predicted)
  • color Light yellow to brown
  • CAS DataBase Reference 478296-72-9(CAS DataBase Reference)
  • FDA UNII 75OCL1SPBQ
  • UNSPSC Code 12352200
  • NACRES NA.21
Hazard and Precautionary Statements (GHS)
  • Symbol(GHS)
  • Signal wordWarning
  • Hazard statements H302-H315-H319-H335
  • Precautionary statements P261-P280-P301+P312-P302+P352-P305+P351+P338

Gabapentin enacarbil Chemical Properties,Usage,Production

  • Description Gabapentin enacarbil (GEn) is an actively transported prodrug of gabapentin that provides sustained doseproportional exposure to gabapentin and predictable bioavailability. In April 2011, Gabapentin enacarbil is approved by the US Food and Drug Administration for the treatment of moderate-to-severe primary restless legssyndrome (RLS) in adults.
    Gabapentin enacarbil was designed to be recognized as a substrate for two high-capacity nutrient transports, monocarboxylate transporter type 1 and sodium-dependent multivitamin transporter, and to be efficiently cleaved after absorption to give gabapentin. The separated enantiomers of gabapentin enacarbil have similar cleavage rates in human tissues. Preclinical studies showed that gabapentin enacarbil provides good systemic exposure of gabapentin in rats and monkeys.
  • Originator Xenoport (United States)
  • Uses Gabapentin enacarbil (HORIZANT GlaxoSmithKline/XenoPort) is a prodrug of gabapentin used as an anticonvulsant as well as a treatment for neurogenic pain, with the same mechanism of action as pregabalin.
  • Definition ChEBI: A carbamate ester that is the N-[1-(isobutyryloxy)ethoxy]carbonyl derivative of [1-(aminomethyl)cyclohexyl]acetic acid. The prodrug for gabapentin, used for treatment of neuropathic pain and restless legs syndrome.
  • Preparation Gabapentin enacarbil is prepared as a racemic mixture from gabapentin either by sequential coupling with 1-chloroethyl chloroformate in the presence of trimethylsilyl chloride and triethylamine followed by addition of isobutyric acid or by direct coupling with an activated 1-(isobutyryloxy) ethyl carbonate.
  • brand name Horizant
  • Pharmacokinetics Gabapentin enacarbil is an acyloxyalkylcarbamate prodrug of analgesic and anticonvulsant drug gabapentin which has problematic pharmacokinetic properties, including short half-life, saturable absorption, high inter-patient variability, and lack of linear dose–response relationship. Gabapentin enacarbil was designed to be absorbed throughout the entire length of the gastrointestinal tract, and its absorption is mediated by high-capacity nutrient transporters, including monocarboxylate transporter 1 (MCT-1) and sodium-dependent multivitamin transporter (SMVT). Prodrug modification produced an extended release of gabapentin with twofold improved, more predictable, and dose-proportional oral bioavailability in humans. During and after its absorption, gabapentin enacarbil is efficiently hydrolyzed by nonspecific esterases to yield gabapentin. Currently, gabapentin enacarbil is commercially available for the treatment of restless legs syndrome and post-herpetic neuralgia of adults.
    Structure and hydrolysis of gabapentin enacarbil to the active gabapentin
    Structure and hydrolysis of gabapentin enacarbil to the active gabapentin
  • Clinical Use Gabapentin enacarbil is a prodrug of gabapentin (Neurontin, Pfizer) which binds to the a2-d subunit of L-type voltage-regulated calcium channels, reducing the release of several neurotransmitters. 122,123 Gabapentin enacarbil was discovered at XenoPort, codeveloped with GlaxoSmithKline, is marketed under the brand name Horizant, and is approved for the treatment of moderate to severe restless leg syndrome. Gabapentin enacarbil was designed to increase the absorption of gabapentin through the interaction with sodium-dependent multivitamin transporter (SMVT) and monocarboxylate transporter type 1 (MCT-1). As a result, the drug demonstrated much better oral bioavailability and more consistent exposure compared to the parent.
  • Synthesis Gabapentin 155 was treated with chlorotrimethylsilane and triethylamine followed by acylation with 1-chloroethyl chloroformate 156 to give acid 157 after hydrolysis of the intermediate silyl ester. This acid was then used without purification and reacted with isobutyric acid (158) and triethylamine to afford gabapentin enacarbil (XIII) in 9.1% overall yield after crystallization. Alternatively, gabapentin 155 was reacted directly with the fully elaborated p-nitrophenyl activated side chain 161 in the presence of potassium carbonate. The resulting mixture of products and p-nitrophenol was treated with 10% Pd/C and potassium formate followed by acidic workup to remove the resulting aniline, providing gabaentin enacarbil (XIII) in 36% overall yield from p-nitrophenol 159 after crystallization. The required activated side chain 161 was prepared from p-nitrophenol 159 via a two-step, one-pot process involving acylation of the phenol with 1-chloroethyl chloroformate 156 in triethylamine. This provided intermediate 160 which was alkylated with isobutyric acid (158) in the presence of zinc oxide and potassium iodide, ultimately furnishing the mixed carbonate 161.

    Synthesis_478296-72-9

  • Mode of action Gabapentin enacarbil is a prodrug of gabapentin and, accordingly, its therapeutic effects in RLS and PHN are attributable to gabapentin.
    The mechanism of action by which gabapentin is efficacious in PHN is unknown but in animal models of analgesia, gabapentin prevents allodynia (pain-related behavior in response to a normally innocuous stimulus) and hyperalgesia (exaggerated response to painful stimuli). Gabapentin prevents pain-related responses in several models of neuropathic pain in rats and mice (e.g., spinal nerve ligation models, spinal cord injury model, acute herpes zoster infection model). Gabapentin also decreases pain-related responses after peripheral inflammation (carrageenan footpad test, late phase of formalin test), but does not alter immediate pain-related behaviors (rat tail flick test, formalin footpad acute phase). The relevance of these models to human pain is not known.
Gabapentin enacarbil Preparation Products And Raw materials
Raw materials
Preparation Products
Gabapentin enacarbil Suppliers
Global(105)Suppliers
  • Supplier：
    Henan Tianfu Chemical Co.,Ltd.
  • Tel：+86-0371-55170693<br/>+86-19937530512
  • Email：info@tianfuchem.com
  • Country：China
  • ProdList：21628
  • Advantage：55
  • Supplier：
    career henan chemical co
  • Tel：+86-0371-86658258<br/>+8613203830695
  • Email：sales@coreychem.com
  • Country：China
  • ProdList：29858
  • Advantage：58
  • Supplier：
    TargetMol Chemicals Inc.
  • Tel：+1-781-999-5354<br/>+1-00000000000
  • Email：marketing@targetmol.com
  • Country：United States
  • ProdList：32202
  • Advantage：58
  • Supplier：
    Xi'an MC Biotech, Co., Ltd.
  • Tel：029-89275612<br/>+8618991951683
  • Email：mcbio_sales@163.com
  • Country：China
  • ProdList：2251
  • Advantage：58
  • Supplier：
    AFINE CHEMICALS LIMITED
  • Tel：+86-0571-85134551
  • Email：sales@afinechem.com
  • Country：China
  • ProdList：15393
  • Advantage：58
  • Supplier：
    InvivoChem
  • Tel：+1-708-310-1919<br/>+1-13798911105
  • Email：sales@invivochem.cn
  • Country：United States
  • ProdList：6391
  • Advantage：58
Gabapentin enacarbil Spectrum
478296-72-9, Gabapentin enacarbilRelated Search:
  • 抑制剂
  • 原料药
  • 杂质对照品
  • 对照品
  • 有机中间体
  • 医药原料
  • 医药原料
  • 加巴喷定恩那卡比
  • 1-[[[[1-(2-甲基-1-氧代丙氧基)乙氧基]甲酰]氨基]甲基]环己基乙酸
  • 加巴喷丁依那卡比
  • 2-(1-((((1-(异丁酰氧基)乙氧基)羰基)氨基)甲基)环己基)乙酸
  • 化合物 T15366
  • 加巴喷丁恩那卡比
  • 加巴喷丁杂质11
  • 1-[[[[1-(2-甲基-1-氧代丙氧基)乙氧基]甲酰]氨基]甲基]环己烷乙酸
  • 加巴喷丁缓释片
  • 478296-72-9
  • Gabapentin enacarbil (XP-13512)
  • inhibit,Calcium Channel,XP 13512,Inhibitor,XP13512,Ca channels,Gabapentin enacarbil,Ca2+ channels
  • 2-(1-((((1-(Isobutyryloxy)ethoxy)carbonyl)amino)methyl)cyclohexyl)acetic acid
  • TIANFUCHEM-478296-72-9---Gabapentin enacarbil
  • 1-[[[[1-(2-Methyl-1-oxopropoxy)ethoxy]carbonyl]amino]methyl]...
  • Gabapentin Impurity 11
  • Gabapentin Enarcarbil
  • XP 13512
  • Cyclohexaneacetic acid,1-[[[[1-(2-Methyl-1-oxopropoxy)ethoxy]carbonyl]aMino]Methyl]-
  • 1-[[[[1-(2-Methyl-1-oxopropoxy)ethoxy]carbonyl]amino]methyl]cyclohexaneacetic acid
  • GABAPENTIN ENACARBIL

Home

My